No Data
Dream Arts has started using "Shop-ran(R)" at 646 stores of Comprehensive Medical's pharmacy.
Dream Arts <4811> announced on the 17th that Comprehensive Medical has introduced "Shopran(R)." Comprehensive Medical plans to implement Shopran(R) starting July 2024 to enhance communication efficiency between headquarters and stores, and will begin full-scale utilization at 646 pharmacies in October 2024. The company aims to expand its operations, which have primarily focused on the dispensing of Pharmaceuticals, to include services as a regular pharmacist and home visits, etc.
Dream Arts --- the financial estimates for the year-end dividends for December 2024 have been revised upward to 40 yen.
Dream Arts <4811> announced on the 13th a revision of the year-end Dividends Financial Estimates for the fiscal year ending December 2024 (January 1, 2024 - December 31, 2024). The company group positions the return of profits to Shareholders as an important management issue. While securing the internal reserves necessary for future growth investments and strengthening the management structure, the basic policy is to continually implement year-end Dividends once a year, aiming for a payout ratio of 20-30%. Investments necessary for enhancing corporate value are essential.
Emerging Markets stock digest: Dream Arts has made a significant rebound, HCH surges sharply.
Shannon (3976) surged 40 points to 569, hitting a new high for the year. After the close of trading on the 13th, Innovation announced that it would conduct a public offering for the company's Stocks and expressed its support, which is viewed positively. This public offering aims to make the company a consolidated subsidiary, but does not intend to delist the company's Stocks. It is expected that the company's Stocks will remain listed on the Tokyo Stock Exchange Growth Market even after the public offering is successful.
Dream Arts, along with Classicom and others.
Below is the downward revision of VIS, with this period's operating profit and loss forecast at -0.214 billion yen, down from -0.144 billion yen. The approximately 0.268 billion yen gain from the sale of Nisso's subsidiary stocks is expected to be recorded as extraordinary profit. A revision of the performance forecast for Astroscale shows this period's project revenue forecast at 12 billion yen, down from 18 billion yen. A public tender offer by Shannon Innovation for Stock 3970 will be made at a price of 650 yen per share, and the listing is expected to be maintained after the public tender offer, with the remaining 25th new share rights.
DreamArts: Notice regarding revisions to the year-end dividend forecast for the fiscal year ending 2024/12
Dream Arts - The capsule toy specialty store "gashacoco" has started using "Shop ran(R)" at approximately 100 locations.
On the 10th, Dream Arts <4811> announced that Happinet Bending Service has introduced "Shopran(R)". Happinet Bending Service will implement Shopran(R) from September 2024, and as of now (November 2024), it is being used in more than 100 locations of the capsule toy specialty store "gashacoco" operated by the company. The company has been implementing a system to enhance multi-store Operation since 2022.
No Data